Press release
North American Oncolytic Virus Therapy Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025
North American oncolytic virus therapy market is estimated to grow at a CAGR of more than 16% during the forecast period. The market growth is attributed to the established research environment for various biotechnologies, the presence of major healthcare providers and growing healthcare investment in the US and Canada. Moreover, a growing number of cancer patients is augmenting the demand for oncolytic virus therapy. T?Vec (talimogene laherparepvec), is a recently approved oncolytic virus drug in the US and Europe. It is the second-generation oncolytic drug armed with GM-CSF to cure cancer.Request a Free Sample of our Report on North American Oncolytic Virus Therapy Market: https://www.omrglobal.com/request-sample/north-american-oncolytic-virus-therapy-market
Research is undergoing other oncolytic virus drugs to cure cancer patients suffering from brain tumors along with breast, lung, liver and bladder cancer. There are other oncolytic virus drugs being researched which include JX?594 (pexastimogenedevacirepvec) for hepatocellular carcinoma, GM?CSF?expressing adenovirus CG0070 for bladder cancer, and Reolysin (pelareorep), a wild?type variant of reovirus for head and neck cancer.
The North America oncolytic virus therapy market is segmented into the US and Canada. The US holds the highest market share in the North American market. The major share of the US market is attributed to the FDA approval of the Imlygic therapy by Amgen Inc., that received approval in the US in 2015. In addition, the increasing prevalence of melanoma further contributes to the growth of the market in North America.
Further, the North American oncolytic virus therapy market is segmented on the basis of product and application. Based on the product, the market is segmented into HSV-based oncolytic viruses, adenoviruses-based oncolytic viruses, vaccinia virus-based oncolytic viruses, vesicular stomatitis virus-based oncolytic viruses, Newcastle disease oncolytic viruses, and other oncolytic viruses. HSV-based oncolytic virus therapy held the highest market share of over 94% in 2018, whereas, adenoviruses-based therapy held the rest.
Based on the application, the market is segmented into prostate cancer, breast cancer, ovarian cancer, melanoma, and others. In 2018, the melanoma application held the largest market share.
The report covers the analysis of several players operating in the North American oncolytic virus therapy market.
In December 2018, Bristol-Myers Squibb Company signed an agreement with PsiOxus Therapeutics, Ltd. to grant the company rights to NG-348, a pre-clinical stage, an armed oncolytic virus which addresses solid tumors. PsiOxus developed tumor-targeted delivery with oncolytic viruses' platform, to target cancer and enable more patients to respond to treatment. The company has continued the study and development of immuno-oncology, which includes development in NG-348, in order to understand the potential of oncolytic viruses to boost checkpoint blockade in several types of cancer.
A Full Report of North American Oncolytic Virus Therapy Market is Available at https://www.omrglobal.com/industry-reports/north-american-oncolytic-virus-therapy-market
North American Oncolytic Virus Therapy Market Segmentation
By Product
o HSV-Based Oncolytic Virus
o Adenoviruses-Based Oncolytic Virus
o Vaccinia Virus-Based Oncolytic Virus
o Vesicular Stomatitis Virus-Based Oncolytic Virus
o Newcastle Disease Virus- Based Oncolytic Virus
o Others
By Application
o Prostate Cancer
o Breast Cancer
o Ovarian Cancer
o Melanoma
o Others
Regional Analysis
o US
o Canada
Company Profiles
o Oncolys BioPharma Inc.
o Otsuka Pharmaceuticals Co. Ltd.
o Shanghai Sunway Biotech Co., Ltd.
o SillaJen, Inc.
o Takara Bio Inc.
o Viralytics Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-oncolytic-virus-therapy-market
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North American Oncolytic Virus Therapy Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025 here
News-ID: 1948000 • Views: …
More Releases from Orion Market Research
![North American ASRS Market | Business Growth, Development Factors, Current and Future Trends till 2031 | Robert Bosch GmbH Toyoda Gosei Co., Ltd. TRW Automotive Holdings Corp.](https://cdn.open-pr.com/L/9/L909708770_g.jpg)
North American ASRS Market | Business Growth, Development Factors, Current and F …
The North American Automated Storage and Retrieval System (ASRS) Market is estimated to generate a significant market value in 2018 and is estimated to grow at a CAGR of 10.1% during the forecast period. North American ASRS Market research report reveals important insights into market scenario to enable key players in taking calculated decision making. Basically, one of the major purposes of market research reports is to maximize the business…
![US ASRS Market | Business Growth, Development Factors, Current and Future Trends till 2031 | Robert Bosch GmbH Toyoda Gosei Co., Ltd. TRW Automotive Holdings Corp.](https://cdn.open-pr.com/L/9/L909807015_g.jpg)
US ASRS Market | Business Growth, Development Factors, Current and Future Trends …
The US automated storage and retrieval system (ASRS) market is estimated to generate a significant market value in 2018 and is estimated to grow at a CAGR of 10.2% during the forecast period. US ASRS Market report provides us with a complete outlook on thorough assessment of thorough data about vital feature of the global industry related to market size, revenue, development and market sales. This study report captures regulatory…
![US Passenger Car Airbag Market | Business Growth, Development Factors, Current and Future Trends till 2031 | Robert Bosch GmbH Toyoda Gosei Co., Ltd. TRW Automotive Holdings Corp.](https://cdn.open-pr.com/L/9/L909652995_g.jpg)
US Passenger Car Airbag Market | Business Growth, Development Factors, Current a …
The US passenger car airbag market is expected to have a modest growth at a CAGR of around 4.5% during the forecast period. US Passenger Car Airbag Market research report allows making important decision making essential for business growth. It helps key participants further in applying right business ideas to grow business and choose the right business doing strategy. Having complete understanding of what purchasers are looking for in the…
![UK Passenger Car Airbag Market | Business Growth, Development Factors, Current and Future Trends till 2031 | Robert Bosch GmbH Toyoda Gosei Co., Ltd. TRW Automotive Holdings Corp.](https://cdn.open-pr.com/L/9/L909301835_g.jpg)
UK Passenger Car Airbag Market | Business Growth, Development Factors, Current a …
UK passenger car airbag market is forecast to have a modest growth at a CAGR of around 5.5% during the forecast period. This informative UK Passenger Car Airbag Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their…
More Releases for Virus
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of…
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Deve …
"The Latest Research Report Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
This report provides an overview of the pipeline landscape for the respiratory tract infections respiratory syncytial virus (RSV) and human parainfluenza virus 3 (HPIV-3).
It provides comprehensive information on the therapeutics under development and key players involved…